` BOLT (Biolight Life Sciences Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

B
BOLT
vs
T
Tel Aviv 355

Over the past 12 months, BOLT has underperformed Tel Aviv 355, delivering a return of +21% compared to the Tel Aviv 355's +53% growth.

Stocks Performance
BOLT vs Tel Aviv 355

Loading
BOLT
Tel Aviv 355
Add Stock
www.alphaspread.com

Performance Gap
BOLT vs Tel Aviv 355

Loading
BOLT
Tel Aviv 355
Difference
www.alphaspread.com

Performance By Year
BOLT vs Tel Aviv 355

Loading
BOLT
Tel Aviv 355
Add Stock

Competitors Performance
Biolight Life Sciences Ltd vs Peers

Tel Aviv 355
BOLT
0KHE
TMO
DHR
207940
Add Stock

Biolight Life Sciences Ltd
Glance View

BioLight Life Sciences Ltd. engages in the management, research and development, investments or sale of solutions, the purpose of which is to address a real need that exists in the field of eye diseases. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.

BOLT Intrinsic Value
26.96 ILS
Overvaluation 95%
Intrinsic Value
Price
B
Back to Top